GLUT1 expression has been shown to be correlated with tumor FDG uptake in salivary gland pleomorphic adenomas [44], esophageal squamous cell carcinoma [45], and high-risk prostate cancer [46]. Here, SLC2A1 is linked to esophageal squamous cell carcinoma.